Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis.

C Pickard1, C Mann, P Sinnott

  • 1Molecular Medicine Unit, St. James's University Hospital, Leeds, UK.

Journal of Neuroimmunology
|December 2, 1999
PubMed
Summary

Interleukin-10 (IL10) gene polymorphisms do not appear to be linked to multiple sclerosis (MS) risk or disease severity in Caucasian populations. This study found no association between IL10 promoter variations and MS development or progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HECTOR: A Trauma Course to Match Our Population.

Irish medical journal·2026
Same author

The intersection of domestic abuse and menopause: a scoping review.

BMC women's health·2025
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Prophylactic endoscopic pylorus dilatation prior to esophagectomy for esophageal cancer to prevent delayed gastric emptying, study protocol for a placebo-controlled randomized trial (PROPPER trial).

Trials·2025
Same author

Low psoas muscle index has a negative impact on survival after minimal invasive esophagectomy for cancer in European men.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024
Same author

Real-world analysis of teclistamab in 123 RRMM patients from Germany.

Leukemia·2024

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Cytokine Biology

Background:

  • Interleukin-10 (IL10) is a key anti-inflammatory cytokine with a potential role in modulating immune responses in neurological diseases.
  • Genetic variations in the IL10 promoter region, specifically at positions -1082, -819, and -519, have been linked to differential IL10 production levels.
  • The -1082*G allele is associated with higher in vitro IL10 production, while the -1082*A allele is linked to lower production.

Purpose of the Study:

  • To investigate the association between common IL10 promoter polymorphisms and the risk of developing multiple sclerosis (MS).
  • To determine if these IL10 polymorphisms influence disease severity and progression in Caucasian MS patients.

Main Methods:

  • Genotyping of three IL10 promoter dimorphisms (-1082, -819, -519) was performed in 185 Caucasian MS patients and 211 ethnically matched controls.

Related Experiment Videos

  • MS patients were stratified based on disease severity and disability outcomes.
  • Statistical analyses were conducted to compare allele and genotype frequencies between cases and controls, and to correlate polymorphisms with disease parameters.

    • Main Results:

    • No statistically significant associations were found between any of the studied IL10 promoter polymorphisms and the risk of multiple sclerosis when comparing patients to controls.
    • Analysis revealed no correlation between IL10 promoter polymorphisms and disease severity or disability progression in the MS patient cohort.
    • The observed allele and genotype distributions for the IL10 polymorphisms did not differ significantly between MS patients and healthy controls.

    Conclusions:

    • IL10 promoter polymorphisms are not associated with susceptibility to multiple sclerosis in the studied Caucasian population.
    • These genetic variations do not appear to influence the clinical course, disability, or progression of multiple sclerosis.
    • Further research may be needed to explore other genetic or environmental factors contributing to MS pathogenesis.